Delivery Order SPE2DB20D3103-SPE2DB25FQ4X8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Armodafinil 250 mg tablets (30-count packages) with a ceiling value of $4,526.16. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.96 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on September 16, 2025, with completion scheduled for September 17, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,232.26 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on September 26, 2025, with a completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader federal contract portfolio. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count) with a ceiling value of $1,446.57. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal medical procurement, with performance based in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency has awarded a delivery order valued at $2,401.31 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,572.46 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order falls under the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4X8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a contract ceiling value of $5,018.26. This competitively awarded, non-set-aside delivery order features firm fixed pricing and is scheduled for ultimate completion by September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle for the Defense Logistics Agency's Medical Supply Chain, enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's significant federal contract portfolio with the DLA demonstrates the company's capability to fulfill diverse medical procurement requirements across multiple therapeutic domains in support of Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/27/25 |